Keita Un

737 citations
22 papers · 625 indexed · h-index 13

Keita Un

22 papers receiving 613 citations

Peers

Keita Un
Comparison fields: 5 of 77
  • Biomaterials 229
  • Biomedical Engineering 270
  • Pharmaceutical Science 36
  • Molecular Biology 309
  • Immunology 90
Replace Jingyi An with:
Jingyi An China
Junxiao Ye China
Jiangkang Xu China
Na Kyeong Lee South Korea
Shrirang Karve United States
Myeong Ju Moon South Korea
Suleixin Yang China
Zili Gu Netherlands
Keita Un relative to Jingyi An China Jingyi An's profile →
Citations per field
00.5×10×20×30×36×
Jingyi An · 1×
Citations per year

Countries citing papers authored by Keita Un

Since Specialization
Citations

This map shows the geographic impact of Keita Un's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keita Un with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keita Un more than expected).

Fields of papers citing papers by Keita Un

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keita Un. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keita Un. The network helps show where Keita Un may publish in the future.

Co-authorship network

The 24 scholars most cited alongside Keita Un, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Keita Un Line = papers co-authored together Keita Un links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201426
2 201411
3 20145
4 20142
5
Intracellular trafficking mechanism of cationic phospholipids including cationic liposomes in HeLa cells.
20144
6 201334
7 201324
8 201316
9 201235
10 201263
11
Enhancement of gene expression by transcriptional activation using doxorubicin-loaded liposome/pDNA complexes.
20124
12 20122
13 201119
14 201122
15 201164
16 201073
17
ドキソルビシン(DOX)抵抗性腫瘍もつマウスにおけるPEGリポソーマルDOXのin vivo抗腫瘍作用:血管内皮細胞に対する細胞毒性作用の関与
20091
18 200953
19 200879
20 200882

About Keita Un

Keita Un is a scholar working on Biomaterials, Molecular Biology and Genetics, having authored 22 papers that have together received 625 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (14 papers), Nanoparticle-Based Drug Delivery (7 papers), Virus-based gene therapy research (5 papers), Ultrasound and Hyperthermia Applications (5 papers), Nanoplatforms for cancer theranostics (4 papers), Angiogenesis and VEGF in Cancer (3 papers), Advanced biosensing and bioanalysis techniques (3 papers) and Viral gastroenteritis research and epidemiology (2 papers). The work is most often cited by research in Biomaterials (229 citations), Biomedical Engineering (270 citations) and Pharmaceutical Science (36 citations). Keita Un has collaborated with scholars based in Japan and United States. Frequent co-authors include Mitsuru Hashida, Fumiyoshi Yamashita, Shigeru Kawakami, Kazuo Maruyama, Ryo Suzuki, Kazutaka Higaki, Toshikiro Kimura, Ken‐ichi Ogawara, Ken-ichi Tanaka and Kumiko Sakai‐Kato. Their work appears in journals such as Biomaterials, Hepatology and Journal of Controlled Release.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026